VVOS — Vivos Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.80m
- $11.13m
- $17.44m
Vivos Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Vivos Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Vivos Therapeutics Reports Q1 Net Loss of $0.07 per Share
Brief: Vivos Therapeutics Reports Q1 Results
Brief: Vivos Therapeutics Receives Notice Of Delisting Or Failure From Nasdaq
Vivos Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: Vivos Therapeutics Announces Additional Strategic Initiatives Aimed At Accelerating Anticipated Timeline For Cash Flow Positive Operations
Brief: Clinical Study Shows 92% Of Patients Report Resolution Of Migraine Headaches Using Vivos' POD Appliance Treatment
Vivos Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Vivos Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Operational Update
Vivos Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Vivos Therapeutics Received Staff Deficiency Notice From Nasdaq Indicating Co No Longer Complies With Minimum Bid Price Requirement
Brief: Vivos Files For Offering Of Up To 13.33 Mln Shares By Selling Stockholder
Brief: Vivos Therapeutics Regains Compliance With Nasdaq Listing Requirements
Brief: Vivos Therapeutics Announces Pricing Of $8 Mln Private Placement
U.S. STOCKS ON THE MOVE-Galmed, NuScale Power, Primoris
Vivos Therapeutics soars as FDA clears sleep apnea device
U.S. STOCKS ON THE MOVE-Tesla, ReneSola, Coinbase
U.S. STOCKS ON THE MOVE-Apple, Starbucks, Vivos Therapeutics